Strides Pharma Science arm New York facility gets 4 USFDA observations
Bengaluru: Strides Pharma Science has announced that the U.S. Food and Drug Administration (USFDA) has concluded inspection with four observations at the Formulations Facility of Strides Pharma Inc. USA (SPI),…
Granules India arm gets 5 USFDA observations for Hyderabad facility
Telangana: Granules India has announced that the U.S. Food and Drug Administration (FDA) has concluded an inspection with five observations at the Hyderabad facility of Granules Life Sciences, a wholly…
Sun Pharma Baska facility gets OAI status from USFDA
Mumbai: Sun Pharma has announced that the company has received Official Action Indicated (OAI) status from the U.S. Food and Drug Administration (USFDA) for Baska facility. The USFDA conducted an…
Solara Active Pharma Sciences Mangalore facility successfully completes USFDA inspection
Chennai: Solara Active Pharma Sciences Limited, an Active Pharmaceutical Ingredient provider, has announced that its multi-product manufacturing facility at Mangalore, Karnataka has successfully completed an inspection by the US Food…
ZyVet releases generic treatment for Canine Urinary Incontinence in US
Pennington: ZyVet Animal Health, a generic pharmaceuticals company for animals, a wholly owned subsidiary of Zydus Pharmaceuticals (USA) Inc., itself a wholly owned subsidiary of Zydus Lifesciences Ltd., a global…
Alembic Pharma gets USFDA nod for Phytonadione Injectable Emulsion for hypoprothrombinemia due to vitamin K deficiency
Vadodara: Alembic Pharmaceuticals Limited has announced that the company has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Phytonadione Injectable…
Motilal Oswal Flags 9–11% Pharma Growth in India by FY 26; Recommends Five Stocks
Motilal Oswal Wealth Management projects India’s pharmaceutical sector to grow at 9–11% by fiscal 2026 and has spotlighted five pharma and healthcare stocks—Lupin, Mankind Pharma, Piramal Pharma, IPCA Labs, and…
Wockhardt’s novel antibiotic Zaynich eyes $9 billion global market
Mumbai-based pharma major Wockhardt, which is all set to launch its new class of antibiotic Zaynich targeted at treating complicated gram-negative infections in India this year, estimates that the drug…
Alembic gets USFDA nod for generic drug
Alembic Pharmaceuticals on Friday said it has received approval from the US health regulator to market a generic medication for the prevention of heart attack and stroke. The company has…
Glenmark shares crash 6% after USFDA order discloses 39 drugs recalled from US market
The shares of Glenmark Pharma crashed over 6 percent on April 9 after the US pharma regulator announced that 39 drugs manufactured by the company, most of which were made…
